MYM Nutraceuticals Inc. , (CSE: MYM) (OTC: MYMMF), is extremely pleased to announce the completion of the architectural layout and security plans for phase one ACMPR greenhouses for the Weedon, QC project.
MYM Nutraceuticals Inc. , (CSE: MYM) (OTC: MYMMF), is extremely pleased to announce the completion of the architectural layout and security plans for phase one ACMPR greenhouses for the Weedon, QC project.
With Marijuana state laws threatened, a new amendment could potentially help to give states the rights they deserve. Occurring on July 27th, Senator Patrick Leahy (D-VT) went to the Senate and successfully proposed and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee which will protect lawful medical marijuana programs from being impeded upon by the Dept. of Justice.
Canada's biggest stock exchange debates U.S. policy
SG Spirit Gold Inc. is pleased to announce that it has received conditional approval from the Canadian Securities Exchange with respect to the proposed three-cornered amalgamation between the Company, Northern Lights Marijuana Company Limited ("DOJA") and a wholly-owned subsidiary of the Company.
Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) today announced that it has strengthened its management team with the appointment of Bernard Fortier to the position of Chief Executive Officer, effective today, July 24, 2017.
InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) has closed a research and development contract with ATERA SAS of France, a key tissue engineering entity specializing in the advancement of innovative human tissue models.
Puration, Inc. (USOTC: PURA) today announced the acquisition of a 25-greenhouse grow operation. PURA operates a U.S. Patented Cannabis Extraction process and sells its extracts for infusion into a variety of consumer products.
Industry Leaders Riding High as Marijuana Demand Outpaces Supply NetworkNewsWire Editorial Coverage Share this article NEW YORK , July 19, The legal marijuana market has been growing by leaps and bounds in North America . Sales jumped 30 percent in 2016, accounting for $6.7 billion in retail activity in the United States and Canada .
MedReleaf Corp. ( TSX: LEAF ), North America's first and only ISO 9001 and ICH-GMP certified producer of cannabis-based pharmaceutical products, today announced a multi-year licensing and distribution agreement with Massachusetts -based CannaKorp Inc. ("CannaKorp"), makers of the world's first single-use, pod-based cannabis vaporizing system, the CannaCloud™.
Aurora Cannabis Inc. (TSXV: ACB) (OTCQX: ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) is pleased to announce that today the Company will be hosting a delegation from Australia , led by the Honourable Jaala Pulford, Minister of Agriculture and Minister for Regional Development for the State of Victoria.
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the second quarter of 2017 generated the largest revenue quarter in the Company's history. Additionally, the Company celebrated the largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway.
ABcann Global Corporation (TSXV: ABCN) this morning announced the signing of a definitive subscription agreement with Cannabis Wheaton Income Corp. (TSXV: CBW).
Cytori Therapeutics (NASDAQ: CYTX) this morning said it has received key patents that strengthen its intellectual property portfolio in the U.S. and Europe, sending shares up 2% mid-morning.
Kush Bottles, Inc. (OTCQB: KSHB), a dynamic sales and distribution platform that provides unique products and services to both businesses and consumers in the regulated cannabis industry, has hired a new sales and support team
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company has already achieved a good number of its goals for 2017. Cannabis Science is aggressively expanding its corporate footprint in legal states throughout the USA, to help self-medicating patients with multiple critical ailments.